Noble Capital Markets Served as Co-Placement Agents to Eledon Pharmaceuticals (ELDN) in $54mm Private Placement
Noble Capital Markets is pleased to announce its role as co-placement agent for Eledon Pharmaceuticals into a securities purchase agreement with certain institutional and accredited healthcare investors for a private investment in public equity financing that is expected to result in gross proceeds of approximately $50 million, before deducting offering expenses.
Noble Capital Markets Initiates Equity Research Coverage on Resources Connection (RGP)
Noble’s Equity Research Analyst Joe Gomes launched coverage on Resources Connection today with his report titled "Poised to Capitalize on a New Paradigm"
Noble Capital Markets Initiates Equity Research Coverage on SKYX Platforms (SKYX)
Noble’s Equity Research Analyst Patrick McCann launched coverage on SKYX Platforms today with his report titled "Initiating Coverage: Introducing Smart Electrical Technology"
Noble Capital Markets Provided Valuation Services To Cox Media Group
Noble Capital Markets is pleased to provide valuation services to Cox Media Group. Noble provided annual impairment analysis per the provisions of Accounting Standards Codification (“ASC”) 350 to Cox Media Group.
Noble Capital Markets Served as Co-Manager to The GEO Group (GEO) in $1.275b Senior Notes Offering
Noble Capital Markets is pleased to announce its role as Co-Manager in The GEO Group, Inc.’s recently announced $1.275 billion Senior Notes Offering. The transaction includes $650 million of 8.625% Senior Subordinated Secured Notes due April 15, 2029 and $625 million of 10.250% Senior Subordinated Unsecured Notes due April 15, 2031.
Noble Capital Markets Initiates Equity Research Coverage on NN Inc. (NNBR)
Noble’s Equity Research Analyst Joe Gomes launched coverage on NN Inc. today with his report titled "A Leading Manufacturer of High-Precision Metal Products"
Noble Capital Markets Served as Valuation to Cumulus Media (CMLS)
April 2024 Noble Capital Markets is pleased to provide valuation services to Cumulus Media, Inc. Noble provided annual impairment analysis per the […]
Noble Capital Markets Initiates Equity Research Coverage on Conduent Inc. (CDNT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on Conduent Inc. today with his report titled "Peering Through The Fog Of Its Transition"
Noble Capital Markets Initiates Equity Research Coverage on SelectQuote (SLQT)
Noble’s Equity Research Analyst Patrick McCann launched coverage on SelectQuote today with his report titled “Can It Cut Loose Its Heavy Debt Anchor?"
Noble Capital Markets Initiates Equity Research Coverage on Unicycive Therapeutics (UNCY)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on Unicycive Therapeutics today with his report titled “Initiating Coverage With An Outperform Rating"
Noble Capital Markets Served as Co-Manager to Kratos Defense & Security Solutions (KTOS) in $345mm Follow-on Offering
Noble Capital Markets is pleased to announce its role as Co-Manager in the completion of Kratos Defense & Security Solutions, Inc.’s recent underwritten follow-on offering of 16,666,667 shares of its common stock at a price of $18.00 per share. The transaction priced on February 22, 2024.
Noble Capital Markets Initiates Equity Research Coverage on ZyVersa Therapeutics (ZVSA)
Noble’s Equity Research Analyst Robert LeBoyer launched coverage on ZyVersa Therapeutics today with his report titled “Novel Therapies For Renal Diseases and Inflammation"
